Boston Therapeutics Inc (OTCBB - OTCQB:BTHE)

0.472
Data as of Apr 15
 0.00 / 0.00%
Today’s Change
0.15
Today|||52-Week Range
1.67
-66.76%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$22.5M

Company Description

Boston Therapeutics, Inc. is a pharmaceutical company, which engages in the development, manufacture, and commercialization of novel compounds based on complex carbohydrate chemistry. Its products include therapeutic modules such as BTI320, Ipoxyn, and Oxyfex. The company was founded by David Platt and Kenneth A. Tassey Jr. on August 24, 2009 and is headquartered in Manchester, NH.

Contact Information

Boston Therapeutics, Inc.
1750 Elm Street
Manchester New Hampshire 03104
P:(603) 935-9799
Investor Relations:

Employees

Shareholders

Individual stakeholders38.71%
Mutual fund holders--
Other institutional--

Top Executives

David PlattChairman, Chief Executive Officer & Treasurer
Kenneth A. TasseyPresident & Director
Louise GelinasDirector-Business Operations
Anthony Don SquegliaChief Financial & Accounting Officer
Hana Chen-WaldenChief Medical Director

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.